Your account is not claimed yet. You can sign up with ORCID to claim your account.

Andrew M Fry

ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 16

Top Venues

Oncogene

Science signaling

Molecular cancer research : MCR

Biology open

University of Leicester

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Leicester Jan 1o 1999

United Kingdom

Dean of Research :: Molecular and Cell Biology

Publications

Anita Singh, Sara Busacca, Aarti Gaba, Michael Sheaff, Charlotte Poile, Apostolos Nakas, Joanna Dzialo, Aleksandra Bzura, Alan G Dawson, Dean A Fennell, Andrew M Fry
BAP1 loss induces mitotic defects in mesothelioma cells through BRCA1-dependent and independent mechanisms. Oncogene (2022)
Anita Singh, Sara Busacca, Aarti Gaba, Michael Sheaff, Charlotte Poile, Apostolos Nakas, Joanna Dzialo, Aleksandra Bzura, Alan G Dawson, Dean A Fennell, Andrew M Fry
BAP1 loss induces mitotic defects in mesothelioma cells through BRCA1-dependent and independent mechanisms. Oncogene 42 (8) (2022)
Kellie Lucken, Laura O'Regan, Jene Choi, Josephina Sampson, Sarah L Pashley, Richard Bayliss, Sam Khan, Andrew M Fry
EML4-ALK Variant 3 Promotes Mitotic Errors and Spindle Assembly Checkpoint Deficiency Leading to Increased Microtubule Poison Sensitivity. Molecular cancer research : MCR 20 (6) (2022)
Anita Singh, Sara Busacca, Aarti Gaba, Michael Sheaff, Charlotte Poile, Apostolos Nakas, Joanna Dzialo, Aleksandra Bzura, Alan G Dawson, Dean A Fennell, Andrew M Fry
BAP1 loss induces mitotic defects in mesothelioma cells through BRCA1-dependent and independent mechanisms. Oncogene (2022)
Anita Singh, Sara Busacca, Aarti Gaba, Michael Sheaff, Charlotte Poile, Apostolos Nakas, Joanna Dzialo, Aleksandra Bzura, Alan G Dawson, Dean A Fennell, Andrew M Fry
BAP1 loss induces mitotic defects in mesothelioma cells through BRCA1-dependent and independent mechanisms. Oncogene (2022)
Anita Singh, Sara Busacca, Aarti Gaba, Michael Sheaff, Charlotte Poile, Apostolos Nakas, Joanna Dzialo, Aleksandra Bzura, Alan G Dawson, Dean A Fennell, Andrew M Fry
BAP1 loss induces mitotic defects in mesothelioma cells through BRCA1-dependent and independent mechanisms. Oncogene 42 (8) (2022)
Anita Singh, Sara Busacca, Aarti Gaba, Michael Sheaff, Charlotte Poile, Apostolos Nakas, Joanna Dzialo, Aleksandra Bzura, Alan G Dawson, Dean A Fennell, Andrew M Fry
BAP1 loss induces mitotic defects in mesothelioma cells through BRCA1-dependent and independent mechanisms. Oncogene 42 (8) (2022)
Savvas Papageorgiou, Sarah L Pashley, Laura O'Regan, Sam Khan, Richard Bayliss, Andrew M Fry
Alternative Treatment Options to ALK Inhibitor Monotherapy for EML4-ALK-Driven Lung Cancer. Cancers 14 (14) (2022)
Naushin L Hindul, Amarjot Jhita, Daiana G Oprea, Tasnim Alamgir Hussain, Oksana Gonchar, Miguel Angel Muro Campillo, Laura O'Regan, Masato T Kanemaki, Andrew M Fry, Kouji Hirota, Kayoko Tanaka
Construction of a human hTERT RPE-1 cell line with inducible Cre for editing of endogenous genes. Biology open 11 (2) (2022)
Anita Singh, Sara Busacca, Aarti Gaba, Michael Sheaff, Charlotte Poile, Apostolos Nakas, Joanna Dzialo, Aleksandra Bzura, Alan G Dawson, Dean A Fennell, Andrew M Fry
BAP1 loss induces mitotic defects in mesothelioma cells through BRCA1-dependent and independent mechanisms. Oncogene 42 (8) (2022)
Josephina Sampson, Mark W Richards, Jene Choi, Andrew M Fry, Richard Bayliss
Phase-separated foci of EML4-ALK facilitate signalling and depend upon an active kinase conformation. EMBO reports 22 (12) (2021)
Sara Busacca, Laura O'Regan, Anita Singh, Annabel J Sharkey, Alan G Dawson, Joanna Dzialo, Aimee Parsons, Neelam Kumar, Laurel M Schunselaar, Naomi Guppy, Apostolos Nakas, Michael Sheaff, Aaron S Mansfield, Samuel M Janes, Paul Baas, Andrew M Fry, Dean A Fennell
BRCA1/MAD2L1 Deficiency Disrupts the Spindle Assembly Checkpoint to Confer Vinorelbine Resistance in Mesothelioma. Molecular cancer therapeutics 20 (2) (2020)
Christopher J Matheson, Christopher R Coxon, Richard Bayliss, Kathy Boxall, Benoit Carbain, Andrew M Fry, Ian R Hardcastle, Suzannah J Harnor, Corine Mas-Droux, David R Newell, Mark W Richards, Mangaleswaran Sivaprakasam, David Turner, Roger J Griffin, Bernard T Golding, Celine Cano
2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase. RSC medicinal chemistry 11 (6) (2020)
Rozita Adib, Jessica M Montgomery, Joseph Atherton, Laura O'Regan, Mark W Richards, Kornelis Straatman, Daniel Roth, Anne Straube, Richard Bayliss, Carolyn A Moores, Andrew M Fry
Mitotic phosphorylation by NEK6 and NEK7 reduces the microtubule affinity of EML4 to promote chromosome congression. Science signaling 12 (594) (2019)
Manjeet Mukherjee, Sarah Sabir, Laura O'Regan, Josephina Sampson, Mark W Richards, Nicolas Huguenin-Dezot, James R Ault, Jason W Chin, Anastasia Zhuravleva, Andrew M Fry, Richard Bayliss
Mitotic phosphorylation regulates Hsp72 spindle localization by uncoupling ATP binding from substrate release. Science signaling 11 (543) (2018)
Andrew M Fry, Josephina Sampson, Caroline Shak, Sue Shackleton
Recent advances in pericentriolar material organization: ordered layers and scaffolding gels. F1000Research 6 (2017)

Andrew M Fry.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Andrew M Fry